Aspect gains licence to brain monitoring technology
This article was originally published in Clinica
Executive Summary
Aspect Medical Systems has obtained an exclusive licence for Cordance, an EEG-based brain assessment tool developed by the company's neuroscience division and UCLA. Newton, Massachusetts-based Aspect hopes to combined Cordance with its proprietary bispectral index (BIS) platform to create new products for diagnosing and treating psychiatric and neurodegenerative diseases such as Alzheimer's disease and depression.